Skip to content

Clinical trials

Leukemia, Myeloid, Chronic-Phase trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Chronic-Phase Country / region: Australia Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20071
20151
20191
20221
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting3
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ascentage Pharma Group Inc.1
Baxalta now part of Shire1
Bristol-Myers Squibb1
Children's Oncology Group1
Enliven Therapeutics1
Novartis Pharmaceuticals1
Takeda1
Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1
The Canadian Blood and Marrow Transplant Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Chronic-Phase9
Leukemia, Myelogenous, Chronic, BCR-ABL Positive5
Leukemia3
Burkitt Lymphoma2
Graft vs Host Disease2
Hodgkin Disease2
Leukemia, Lymphocytic, Chronic, B-Cell2
Leukemia, Myeloid, Accelerated Phase2
Lymphoma2
Lymphoma, B-Cell, Marginal Zone2

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.